CBP/p300 values and HAT activity. Moreover, EC pretreatment counteracted the increased acetylation of H3K9 and H3K4 dimethylation and attenuated the diminished H3K9 dimethylation triggered by HG. EC also significantly decreased HG-enhanced HDAC4 levels and TNF-α release, respectively. Conclusions EC induces epigenetic changes and decreased NF-κB and TNF-α levels in human monocytes cultured in HG conditions such as in diabetes.
Introduction
Diabetes is characterised by a sustained hyperglycaemia that stimulates the inflammatory response [1] . High glucose leads to the activation of the transcriptional factor nuclear factor-κ B (NF-κB) and activates the expression of inflammatory cytokines, including tumour necrosis factor (TNF)-α and interleukin (IL)-6, in THP-1 cells and monocytes from diabetic individuals [1, 2] . p65 is the key transcriptionally active component of NF-κB and requires CBP/p300 for its transactivation to modulate gene expression [1] .
Epigenetic histone modifications are considered major underlying mechanisms for sustained pro-inflammatory phenotype of diabetic cells [3, 4] . Histone acetylation stimulated by histone acetyl transferases (HATs) increases accessibility to transcription factors to induce gene transcription. On the other hand, histone deacetylation by histone deacetylases (HDACs) promotes DNA winding and therefore gene repression [1, 3] . Histone methylation has
Abstract
Purpose Diabetes is a pro-inflammatory state associated with increased monocyte activity. NF-κB is the master switch of inflammation and is activated during diabetes. (−)-Epicatechin (EC), the main cocoa flavonol, displays anti-inflammatory and anti-diabetic effects under high glucose conditions. Recently, it has been suggested that dietary polyphenols might modulate chromatin remodelling by epigenetic changes and regulate monocyte NF-κB activation and cytokine expression under diabetic conditions. The aim of the study was to test the potential anti-inflammatory role of EC via inducing posttranslational histone changes in the presence of a high glucose (HG) concentrations. Methods Human monocytic cells (THP-1 cells) were pretreated with EC (5 μM) and 4 h later exposed to 25 mM glucose (HG) for a total of 24 h. Control cells were grown under normoglycemic conditions (NG, 5.5 mM glucose). Acetyl CBP/p300, HDAC4, total histone 3 (HH3), H3K9ac, H3K4me2 and H3K9me2, and phosphorylated and total levels of p65-NF-κB were analysed by Western blot. Histone acetyltransferase (HAT) activity was measured in nuclear lysates, and TNF-α release was evaluated in culture media. Results EC incubation restored to control levels (NG) the changes induced by HG in p-p65/p65-NF-ĸB ratio, acetyl variable effects on transcription regulation; thus, histone H3 lysine 4 dimethylation (H3K4me2) has been associated with gene activation, whereas histone H3 lysine 9 dimethylation (H3K9me2) seems to be related to gene repression [3, 5] . In concert, hyperglycaemia enhances monocyte activation by increasing H3K9 acetylation (H3K9ac) and H3K4me2 and decreasing H3K9me2, allowing the binding of NF-κB to inflammatory genes [1, 2, 5] .
(−)-Epicatechin (EC) is one of the most abundant flavonoids in human diet, being present in high concentrations in grapes, cocoa, tea and many other fruits and vegetables [6] . EC exerts anti-diabetic, antioxidant and anti-inflammatory effects [6] . Consequently, EC decreased p65-NF-κB induction evoked by lipopolysaccharide stimulation in monocytes [6] . However, the precise mechanism for the anti-inflammatory effects of EC is not fully understood.
In view of all this evidence, it could be hypothesised that EC could exert an anti-inflammatory effect in diabetes through inducing epigenetic changes. Thus, the protective effect of EC on inflammatory markers, namely NF-κB and TNF-α, and posttranslational modifications of key histones in high-glucose-challenged human monocytes were studied.
Materials and methods

Materials and chemicals
(−)-EC (>95 % of purity) and d-glucose were purchased from Sigma (St Louis, MO, USA). Anti-TATA was obtained from Abcam (Cambridge, MA, USA). All other antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). HAT activity colorimetric assay kit and Milliplex MAP kit were obtained from Biovision (Mountain View, CA, USA). NE-PER nuclear and cytoplasmic extraction reagents and BCA kit were purchased from Pierce (Rockford, IL, USA). Histone purification kit was obtained from Active Motif (Carlsbad, CA, USA).
Cell culture and treatment
Human THP-1 cells were grown in RPMI medium supplemented with 10 % foetal bovine serum and 1 % antibiotics. Cells were maintained at 37 °C in a humidified atmosphere of 5 % CO 2 . Cells were maintained under normoglycemic conditions (NG, 5.5 mM glucose) or pre-incubated with 5 μM EC and 4 h later, exposed to 25 mM glucose (high glucose, HG) for a total of 24 h and then harvested. Mannitol was used as hyperosmolar control.
TNF-α release measurement
TNF-α levels were measured with a Milliplex MAP Assay kit according to the manufacturer's instructions. Values were calculated based on a standard curve constructed for the assay [1] .
Preparation of nuclear lysates
Nuclear lysates were prepared using a commercial kit. Lysates were collected, assayed for protein concentration by BCA protein assay kit according to the manufacturer's specifications, aliquoted and stored at −80 °C [1] .
Measurement of HAT activity
Nuclear lysate protein (50 μg) was taken for determination of HAT activity according to the manufacturer's instructions. Absorbance was measured at 440 nm [1] .
Histone purification
Histone purification was performed with a commercial kit following the manufacturer's instructions. The pellet was air-dried, histone-resuspended in sterile water and stored at −80 °C.
Western blot analysis
Equal amounts of nuclear lysates or purified histones were separated by SDS-polyacrylamide gel electrophoresis, transferred onto nitrocellulose membranes and probed with the corresponding primary antibody followed by incubation with peroxide-conjugated anti-rabbit or anti-mouse immunoglobulin. Blots were developed with the ECL system (GE Healthcare). Normalisation of Western blot was ensured by TATA binding protein, and bands were quantified using a scanner and accompanying software.
Statistics
Prior to statistical analysis, data were tested for homogeneity of variances by the test of Levene; for multiple comparisons, one-way ANOVA was followed by the Bonferroni test when variances were homogeneous or by the Tamhane test when variances were not homogeneous. P < 0.05 was considered significant. A SPSS version 22.0 program has been used. Data were obtained by performing 3 independent experiments in duplicate.
Results
HG significantly enhanced p-p65-NF-ĸB levels in nuclear lysates, and this increase was abrogated by pre-treatment with EC (Fig. 1a) . There was no alteration in total p65-NF-ĸB values resulting in significant attenuation of p-p65/ p65 ratio with EC treatment (Fig. 1b) . In agreement, HG incubation increased TNF-α release in THP-1 cells, whereas EC pre-treatment partly prevented the enhancement in the cytokine secretion (Fig. 1c) . These results suggest that EC alleviates the inflammatory response induced by HG in monocytes. Figure 2a , b shows that HG incubation increased acetyl CBP/p300 levels, but this effect was totally repressed by EC pre-incubation. Additionally, EC pre-treatment prevented the enhanced HDAC4 levels evoked by HG Means with unlike letters were significantly different (P < 0.05) 1 3 (Fig. 2c) . HDAC1, HDAC2 and HDAC3 levels were not modified by any treatment (data not shown). Moreover, HAT activity was increased in HG-challenged cells, but EC pre-treatment restored HAT activity to control levels (Fig. 2d) .
The analysis of the posttranscriptional histone modifications showed that HG treatment enhanced H3K9ac and H3K4me2 levels and decreased H3K9me2 levels, which could suggest a plausible explanation for stimulation of TNF-α gene expression (Fig. 3) . However, EC pre-treatment prevented all these alterations and restored all values to control levels, indicating a protective effect against the epigenetic changes induced by HG.
Discussion
Chronic inflammation is implicated in the majority of diabetic vascular complications [4] . Several studies indicate that high-glucose-mediated activation of NF-ĸB and cytokine expression in monocytes is related to epigenetic changes [1, 2, 4] . In this regard, lifestyle and diet can affect epigenetic alterations and might exert protective effects against the maintenance of the metabolic memory [7] . Here we show that EC alleviates HG-induced inflammatory response by preventing the increase in p-p65-NF-ĸB levels and TNF-α release in THP-1 cells. In concert, other authors have reported that EC metabolites abrogated p65-NF-ĸB activation in human monocytes under pro-inflammatory conditions [6] . Moreover, EC pre-treatment prevented HG-induced H3K9ac and H3K4me2 increases, and H3K9me2 decrease in THP-1 cells. These features could be related to a beneficial effect evoked by EC against HG-induced inflammation (enhanced NF-ĸB and TNF-α levels). In agreement, other polyphenols such as curcumin, epigallocatechin-3-gallate and resveratrol exerted anti-inflammatory effects under HG conditions, and these outcomes were related to chromatin remodelling, histone acetylation inhibition and modulation of histone methylation in monocytes and hepatic cells [1, 7, 8] . Additionally, cocoa, which is a rich source of EC, decreased global DNA methylation of peripheral leucocytes in humans with cardiovascular risk factors [9] .
HATs and HDACs are involved in chromatic remodelling and play an important role regulating the pro-inflammatory response [1] . NF-ĸB coactivator, CBP/p300, possesses intrinsic HAT activity leading to histone acetylation and facilitating pro-inflammatory gene expression [1] . Thus, H3K9 deacetylation at chromatin contributes to decreased NF-ĸB signalling [10] . Here it is shown that EC pre-treatment restored CBP/p300 levels and HAT activity to control values, which could contribute to decrease in p-p65 levels and TNF-α release. Similarly, curcumin was shown to prevent HAT (p300) activation in THP-1 cells under HG challenge and likely prevented p300 recruitment to TNF-α and IL-6 promoters [1] . Therefore, it could be inferred that the chromatin remodelling induced by EC prevented p65-NF-ĸB binding to TNF-α promoter and expression during HG, but further studies are needed.
HDACs play very distinct functions [11] . Upregulated HDAC4 has been associated with inflammatory and podocyte loss in response to common detrimental factors in diabetes [11] . Although further studies are needed, we show that HDAC4 inhibition induced by EC pre-treatment could be related to a protective effect in HG-challenged THP-1 cells.
It could be highlighted that EC dose employed in this work is physiological as in human serum 6 µM EC has been detected after 26 g of cocoa intake [12] and this Means with unlike letters were significantly different (P < 0.05) concentration is within the range recommended for in vitro studies [13] .
In summary, EC induced epigenetic changes on posttranslational histone modifications, modulated HAT (p300) and HDAC4 levels as well as decreased NF-κB expression levels and TNF-α release in THP-1 cells under HG conditions. Altogether, these data indicate that EC may be helpful in reducing vascular inflammation and diabetic complications. Future studies will involve a complete characterisation of epigenetic changes that EC causes in vivo in diabetics.
